| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |